Tag Archives: san antonio breast cancer symposium
Ribociclib Plus Endocrine Therapy Shows Consistent Benefit and Safety in Elderly Patients with Advanced Breast Cancer
Ribociclib plus endocrine therapy offers consistent benefits for elderly patients with HR+, HER2- advanced breast.....Read more
26
Nov
Nov
Nivolumab Improves pCR in High-Risk ER-Positive, HER2-Negative Breast Cancer Patients with Higher PD-L1 Expression
Nivolumab improves pCR rates in high-risk ER+, HER2- breast cancer patients with higher PD-L1 expression,.....Read more
26
Nov
Nov